Introduction {#S0001}
============

Juvenile idiopathic arthritis (JIA) represents an array of biologically distinct, incompletely understood forms of chronic inflammatory arthritis beginning in childhood. JIA has been classified into six or seven categories based on associated clinical and laboratory features.[@CIT0001],[@CIT0002] Recent approaches incorporating biologic information from cytokine profiles and genetics have led to alternative proposed classifications of JIA.[@CIT0003],[@CIT0004] JIA is thought to originate from a complex interplay of non-Mendelian genetics[@CIT0005] and environmental influences leading to chronic inflammation of joints and other tissues.[@CIT0006] Familial epidemiologic studies and genome-wide association studies have produced estimates of the contribution of genetic factors to JIA ranging from 13% to 25%.[@CIT0007]--[@CIT0009] While these numbers could rise with advancements in genetics,[@CIT0010] physicians and families alike grapple with questions about the sizable missing heritability of JIA specifically with the potentially outsized role of the environment on JIA pathogenesis.

Mechanistically, environmental influences may trigger JIA via several different mechanisms, including epigenetic changes, imbalance of microbiota, and direct modulation of the immune system. In keeping with Dr. Barkers hypothesis that postulates adult diseases might have their origins in utero,[@CIT0011] we also discuss links between postulated in utero exposures including maternal smoking and others with JIA. Details about these potential mechanisms, including relevant references, have been reviewed elsewhere.[@CIT0012]--[@CIT0014] In this narrative review, we discuss recent advances in our understanding of environmental factors that might relate to JIA pathogenesis and highlight some limitations of research on environmental influences on disease.

Environmental factors and JIA {#S0002}
=============================

Potentially protective factors {#S0002-S2001}
------------------------------

### Breast-feeding {#S0002-S2001-S3001}

Breastfeeding has been associated with numerous health benefits, including possible prevention of immune-mediated diseases.[@CIT0015] Breastmilk contains natural prebiotics and probiotics and has been linked to favorable changes in infants' gut microbiota (e.g., increased commensal *Bifidobacteria*, reduced potentially pathogenic commensals \[pathobionts\],[@CIT0016]--[@CIT0020] alteration in DNA methylation profiles,[@CIT0021] and other immunologically protective factors (e.g., soluble IgA, IgG, IL-10, TGFb, defensins).[@CIT0022]

Multiple prior studies have examined the connection between breastfeeding and JIA, reporting disparate findings ([Table 1](#T0001){ref-type="table"}). The first publication on this topic, a case-control study, reported a potentially protective effect, with a lower frequency of breastfeeding in JIA (37%) than in unaffected peers (60%).[@CIT0023] Cases were less likely to breastfeed for \>3 months compared to controls (15% vs 34%). This study, however, had several methodologic limitations, including a small sample size with questionable generalizability, unmeasured confounding, and the potential for selection bias and recall bias ([Table 1](#T0001){ref-type="table"}). Subsequent case-control studies did not show a significantly decreased risk of JIA among breastfed children;[@CIT0024]--[@CIT0028] one among them reported an increased risk of oligoarticular JIA in breastfed children.[@CIT0028] While all but one of these studies were larger, they, too, had similar limitations ([Table 1](#T0001){ref-type="table"}). A recent study from southeast Sweden reported that breastfeeding could delay or prevent JIA in some children.[@CIT0029] Unlike all other previous research on this topic, this study was performed within a population-based birth inception cohort that prospectively collected information about early feeding practices, well before JIA was diagnosed. Children who developed JIA were significantly less likely to breastfeed for more than 4--6 months after adjustment for multiple factors, including parental education, family history, early life infections, and smoke exposure. As a negative control, there was no evident association between early life feeding and transient forms of arthritis, lending specificity to the correspondence between breastfeeding and JIA. A multicenter study of a UK-based JIA cohort suggested that early breastfeeding could modify JIA phenotype and severity.[@CIT0030] In this cohort, breastfed children were more likely to be diagnosed at younger ages and have better physician global, parent global, pain, and physical function (Childhood Health Assessment Questionnaire, CHAQ) scores, with longer durations of breastfeeding corresponding to progressively lower scores. However, group differences in global, pain, and functional scores may have been related to unmeasured confounders; parent global scores differed between groups more markedly than physician scores, and there were no apparent differences between groups in active joint counts or inflammatory markers.Table 1Summary of studies of selected environmental risk factors and juvenile idiopathic arthritisReferenceSettingDesignPopulationKey result(s)Covariate adjustmentNotes and limitations**Breastfeeding**Mason 1995[@CIT0023]2 centers, SE USCC, BF data from phone survey54 children with oligo/poly JRA (ARA criteria), 79 peer controlsBF, all JRA: OR 0.4 (95% CI: 0.2--0.8)\
BF, oligo JRA OR 0.3 (95% CI: 0.2--0.9)\
BF, poly JRA OR 0.6 (95% CI: 0.2--1.7)None; peers were matched by age, race, and presumably location; no significant differences between groups in maternal age or educationSmall sample sizeQuestionable generalizability (2 centers, only white participants)Unmeasured confounding (e.g., genetics, SES)Potential selection bias (29% participation; participants reported lower breastfeeding rates than nonparticipants; peer controls)Potential recall or social desirability bias (self-reported BF data)Rosenberg 1996[@CIT0024]1 center, central CanadaCC, BF data from written questionnaire137 children with oligo/poly JRA (ACR criteria), 331 peer controls; second random age-matched control subsetBF, all JRA OR 1.3 (95% CI: 0.9, 2.0)^1^\
BF, oligo JRA, peer control: OR 2.2 (95% CI: 0.9--5.4); random control: OR 0.9 (95% CI: 0.5--1.8)\
BF, poly JRA, peer control: OR 1.2 (95% CI: 0.3--4.2); random control: OR 0.5 (95% CI: 0.2--1.2)None; peers were matched by age, race, and location; no significant differences between groups in parental education or occupationImprecise estimatesQuestionable generalizability (1 center)Unmeasured confounding (e.g., genetics, SES)Potential selection bias (number of eligible non-participants NR; peer controls)Potential recall or social desirability bias (self-reported BF data)Kasapçopur 1998[@CIT0027]1 center, TurkeyCC, BF data from in-person survey53 children with oligo/poly/systemic JRA (ARA criteria), 32 controls with nephrotic syndrome, 54 healthy controls (unclear source)BF duration, all JRA: 12.6 months (SD 10.4)\
BF duration, oligo JRA: 9.0 (SD 10.1) (OR 0.6, 95% CI: 0.1--5.3)\
BF duration, HC: 10.8 (SD 10.1)None; no significant differences between groups in maternal age at birthSmall sample sizeQuestionable generalizability (1 center)Unmeasured confounding (e.g., genetics, SES)Potential selection bias (number of eligible non-participants NR; unclear source of controls)Potential recall or social desirability bias (self-reported BF data)Radon 2010[@CIT0028]1 hospital, SW GermanyCC, BF data from written questionnaire238 children with oligo JIA (ILAR criteria), 832 hospital-based controls undergoing strabismus surgery at nearby hospitalBF duration ≥6 months: OR 1.6 (95% CI 1.2--2.3)Age, sex, region, duration of schooling, low birth weight, prenatal maternal smoking, allergic rhinitis, rural residence, farm residence before age 1Questionable generalizability (1 center)Unmeasured confounding (e.g., genetics, SES)Potential selection bias (hospital-based controls)Potential recall or social desirability bias (self-reported BF data)Ellis\
2012[@CIT0025]1 center, SE AustraliaCC, BF data from written questionnaire262 children with JIA (ILAR criteria), 458 hospital-based regional controls undergoing elective surgeryBF, all JIA: OR 0.9 (0.4--1.9)Age, sex, Caucasian ancestry, residence-based socioeconomic indexImprecise estimatesQuestionable generalizability (1 center)Unmeasured confounding (e.g., genetics, SES)Potential selection bias (hospital-based controls)Potential recall or social desirability bias (self-reported BF data)Shenoi 2016[@CIT0026]1 center, USCC, BF data from written questionnaire225 children with JIA diagnosed by pediatric rheumatologists, 138 age- and sex-matched peer controlsBF, all JIA: OR 1.2 (95% CI 0.9--1.5)^1^Age, annual household incomeQuestionable generalizability (1 center)Unmeasured confounding (e.g., genetics)Potential selection bias (36% nonresponse, peer controls)Potential recall or social desirability bias (self-reported BF data)Playmate controls were age and gender-matchedHyrich 2016[@CIT0030]5 centers, UKRC, BF data from in-person interview923 children with JIA (ILAR criteria), characterized by BF historyBF, all JIA: median age of onset 5.7 vs 7.6 (*P*\<0.001); median PhGA^2^ 28 vs 32 (*P*=0.03); median PGA^2^ 23 vs 39 (*P*\<0.001); median pain score^2^ 18 vs 29 (*P*\<0.001); median CHAQ^2^ 0.63 vs 0.88 (*P*\<0.001); CHAQ \>0.75 OR 0.6 (95% CI 0.4, 0.95)Exploratory analysis of BF and CHAQ: onset age, gender, race, hospital, disease duration, JIA category, disease activity, limited joint count, geographic socioeconomic indexUnmeasured confoundingPotential selection bias (26% nonresponse)Potential recall or social desirability bias (self-reported BF data)Kindgren 2017[@CIT0029]1 region, SE SwedenRC, prospectively collected BF data from written questionnaire32 children with JIA (per local pediatric rheumatologists), 111 children with TA, 10,883 children without arthritisExclusive and total BF ≥0.4 months, all JIA: OR 0.4 (95% CI: 0.2--0.8)^1^; total BF ≥0.6 months, all JIA: OR 0.3 (95% CI: 0.2--0.6); exclusive BF ≥0.4 months, TA: OR 0.8 (95% CI: 0.5--1.1)^1^; total BF ≥0.6 months, all JIA: OR 1.0 (95% CI: 0.7, 1.4)^1^Age, parity, mode of delivery, preterm birth, infections during the first year of life, introduction of formula, parental education, smoking, country of birth, JIA or RA in first- and second-degree relativesSmall sample sizeQuestionable generalizability (1 region)Unmeasured confounding (e.g., SES, antibiotics)Potential selection bias (24% nonresponse)Prospective, self-reported BF data with low chance of recall bias**Siblings or birth order**Nielsen 1999[@CIT0035]2 clinics+all hospitals, DenmarkNCC, sibling data from national register220 children with JCA (EULAR criteria), 880 age-, sex-, region-matched random controlsAny sibling, all JCA: OR 0.6 (95% CI: 0.5--0.9)Age, sex, region, parental income, housing (rural, house, flat)Questionable generalizability (1 country, hospital-based)Unmeasured confounding (e.g., genetics, infections, antibiotics, mode of delivery)Potential selection bias (hospital-based)Prahalad 2003[@CIT0036]1 clinic, SW USCC, birth order from birth certificates333 children with JIA (ILAR criteria), 3295 age- and sex-matched controls≥2nd birth, all JIA: OR 1.5 (95% CI: 0.96--2.5)^1^Age, sex; no differences between groups in maternal ageQuestionable generalizability (1 clinic)Unmeasured confounding (e.g., genetics, SES)Carlens 2009[@CIT0037]All hospitals, SwedenNCC, sibling data from national register3334 children with JIA (criteria or validity NR), 13,336 random age-, sex-, region-matched controls1--2 older siblings, all JIA: OR 1.0 (95% CI: 0.9--1.1); ≥3 older siblings, all JIA: OR 0.9 (95% CI: 0.8--1.1)Age, sex, region, civil status, season of birth, mode of delivery, gestational age, birthweight, maternal age, maternal smokingQuestionable generalizability (1 country, hospital-based)Unmeasured confounding (e.g., genetics, SES)Potential selection bias (hospital-based)Miller\
2015[@CIT0038]1 clinic, SE AustraliaCC, sibling data from written questionnaire302 children with non-systemic JIA (ILAR criteria), 676 hospital-based controls, 341 community controls1 household sibling, all JIA, hospital controls: OR 0.5 (95% CI: 0.3--0.8); 1 household sibling, all JIA, community controls: OR 0.4 (95% CI: 0.2--0.8); ≥3 household siblings, all JIA, hospital controls: OR 0.3 (95% CI: 0.1, 0.4); 1 household sibling, all JIA, community controls: OR 0.5 (95% CI: 0.2, 1.3)Age, sex, gestational age at birth, maternal age at birthQuestionable generalizability (1 center)Unmeasured confounding (e.g., genetics, SES)Potential selection bias (hospital-based controls)Bell\
2017[@CIT0039]1 clinic, NW USNCC1252 children with JIA (ILAR criteria), 6072 random age-, and sex-matched regional controls1 prior birth, all JIA: 0.95 (95% CI: 0.8--1.1); ≥4 prior births, all JIA: 0.95 (95% CI: 0.8--1.1)Birth year, maternal age; no statistical confounding detected from sex, paternal age, maternal race/ethnicity, educational level, prenatal smoking, marital status, insurance; trimester that prenatal care beganQuestionable generalizability (1 center)Unmeasured confounding (e.g., genetics, SES)**Antibiotics**Arvonen\
2015[@CIT0052]Finland, national dataNCC, antibiotic data from dispensing data1298 children with JIA taking reimbursed antirheumatic drugs (e.g., prednisone, methotrexate, biologic); 5179 age-, sex-, birth region-matched controlsAny antibiotics, all JIA: OR 1.6 (95% CI: 1.3--1.9); ≥4 antibiotic courses, all JIA: OR 1.9 (95% CI: 1.5--2.3)Age, sex, region of birthQuestionable generalizability (1 country, likely exclusion of some oligoarticular JIA)Unmeasured confounding (e.g., genetics, SES, infections)Potential reverse causalityHorton\
2015[@CIT0053]550 general practices, UKNCC, antibiotic from prescribing data152 children with JIA (validated codes; more specific secondary case definitions), 1520 age-, sex-matched controlsAny antibiotics, all JIA: OR 2.1 (95% CI 1.2--3.5); ≥6 antibiotic courses, all JIA: OR 3.0 (95% CI 1.6--5.6); antibiotics in most recent 6 months, all JIA: OR 3.1 (95% CI 1.7--5.5); nonbacterial antimicrobial, all JIA: OR 1.2 (95% CI 0.7--1.9)Age, sex, any infection, any personal autoimmune disease; secondarily adjusted for maternal history of autoimmune disease, number of recent clinic visits, hospitalizationQuestionable generalizability (1 country)Unmeasured confounding (e.g., SES, unrecorded infections)Potential misclassification of JIA diagnosisPotential reverse causality**Cesarean section**Carlens 2009[@CIT0037]All hospitals, SwedenNCC, sibling data from national register3334 children with JIA (criteria or validity NR), 13,336 random age-, sex-, region-matched controlsCS, all JIA: OR 1.2 (95% CI: 1.02, 1.3)Age, sex, region, civil status, season of birth, older siblings, gestational age, birthweight, maternal age, maternal smokingQuestionable generalizability (1 country, hospital-based)Unmeasured confounding (e.g., genetics, SES)Potential selection bias (hospital-based)Ellis\
2012[@CIT0025]1 center, SE AustraliaCC, birth data from written questionnaire262 children with JIA (ILAR criteria), 458 hospital-based regional controls undergoing elective surgeryCS, all JIA: 22.5% vs 27.1% (OR 0.8, 95% CI: 0.4, 1.5)^1^None (adjusted analysis not shown)Imprecise estimatesQuestionable generalizability (1 center)Unmeasured confounding (e.g., genetics, SES)Potential selection bias (hospital-based controls)Shenoi 2016[@CIT0026]1 center, USCC, birth data from written questionnaire225 children with JIA diagnosed by pediatric rheumatologists, 138 age- and sex-matched peer controlsCS, all JIA: OR 1.1 (95% CI: 0.5--2.1)Age, annual household incomeImprecise estimatesQuestionable generalizability (1 center)Unmeasured confounding (e.g., genetics)Potential selection bias (36% nonresponse, peer controls)Playmate controls were age and gender-matchedSevelsted 2015[@CIT0062]Denmark, national dataRC, CS from national register data1.9 million children born 1973--2012, JIA by ICD-10 codesCS, all JIA: IRR 1.1 (95% CI: 1.02--1.2)Age, calendar year, birth weight, parity, sex, season of birth, maternal age, maternal diagnosis of arthritisQuestionable generalizability (1 country, premature births excluded)Small effect size with possible unmeasured confounding (e.g., genetics, SES, antibiotics)Potential misclassification of JIA diagnosisKristensen 2016[@CIT0063]Denmark, national dataRC, CS type from national register data1.0 million children born 1997--2012, JIA by ICD-10 codesElective CS, all JIA: HR 1.3 (95% CI: 1.04, 1.5); acute CS, all JIA: OR 0.99 (95% CI: 0.8, 1.2)Gestational age at birth, birth weight, sex, maternal age, maternal smoking, maternal pregnancy complicationsQuestionable generalizability (1 country)Small effect size with possible unmeasured confounding (e.g., genetics, SES, antibiotics)Potential misclassification of JIA diagnosis**Second-hand smoke exposure**Carlens 2009[@CIT0037]All hospitals, SwedenNCC, sibling data from national inpatient register3334 children with JIA (criteria or validity NR), 13,336 random age-, sex-, region-matched controls, ICD codes usedOR 1.0; 95% CI: 0.8--1 (maternal prenatal smoking)Age, sex, region, civil status, season of birth, older siblings, gestational age, birthweight, maternal age, maternal smokingQuestionable generalizability (1 country, hospital-based)Unmeasured confounding (e.g., genetics, SES)Potential selection bias (hospital-based)Smoking being a non-desirable trait likely underreportedShenoi 2016[@CIT0026]1 center, USCC, birth data from written questionnaire225 children with JIA diagnosed by pediatric rheumatologists, 138 age- and sex-matched playmate controlsOR 0.8, 95% CI: 0.3--2.7 (for maternal prenatal smoking)\
OR 0.8, 95% CI: 0.5--1.4 (for household smoking)Age, annual household incomeImprecise estimatesQuestionable generalizability (1 center)Unmeasured confounding (e.g., genetics)Potential selection bias (36% nonresponse, peer controls)Smoking being a non-desirable trait likely underreportedPotential overmatching as playmate controls usedJaakkola 2005[@CIT0070]Finnish\
Nationwide medical birth registry\
cohort 31 JIA casesRC of singleton births born in 1987 and followed until 7 years58,841 singleton births from the Finnish Medical Birth Registry, 31 JIA cases identifiedOR 6.9; 95% CI: 2.0--22.9 restricted to girls (maternal prenatal smoking)Adjusted for gender, birth order, maternal age, marital status, and maternal occupation. Fetal growth and preterm delivery were\
considered as potential confoundersSmall number of JIA cases identified due to study designPotential selection biasNo data on postnatal environmental smoke exposureSmoking being a non-desirable trait likely underreportedFranca 2018[@CIT0071]Brazilian, single center tertiary hospital at Sao PauloCC, structured environmental questionnaire66 JIA, 124 controls, ILAR criteria for JIA diagnosisOR 3.4; 95% CI: 1.5--8.1 (intrauterine cigarette exposure),\
OR 3.6, 95% CI:\
1.8--7.3 (Secondhand postnatal smoke exposure)Age- and gender-matched controlsPotential unmeasured confoundingRecall biasPotential referral bias using convenience sample from tertiary hospitalSmoking being a non-desirable trait likely underreportedEllis\
2012[@CIT0025]1 center, SE AustraliaCC, using written questionnaire262 children with JIA (ILAR criteria), 458 hospital-based regional controls undergoing elective surgeryOR 0.6, 95% CI: 0.4--0.99 (maternal prenatal smoking),\
OR 0.61; 95% CI: 0.4--0.9 (paternal smoking)Age, sex, Caucasian ancestry, residence-based socioeconomic index.\
Adjusting for maternal socioeconomic status or maternal age at child's birth or child's age/sex and Caucasian ancestry mitigated this effect for maternal, but not paternal smokingImprecise estimatesQuestionable generalizability (1 center)Unmeasured confounding (e.g., genetics, SES)Potential selection bias (hospital-based controls)Potential recall biasSmoking being a non-desirable trait likely underreportedShenoi 2015[@CIT0069]Single center, WA stateCC, population based, linked outpatient and hospital data with WA state birth certificate data1196 JIA cases; 5618 controls, validated ICD-10 JIA casesOR 0.7; 95% CI: 0.6--0.9 (maternal prenatal smoking)Controls were frequency matched on birth year\
Adjusted for maternal age and marital statusPotential unmeasured confoundingSmoking being a non-desirable trait likely underreportedNo data on postnatal environmental smoke exposure**Diet**Arvonen 2017[@CIT0077]Finland, national dataNCC, antibiotic data from dispensing data1298 children with JIA taking reimbursed antirheumatic drugs (e.g., prednisone, methotrexate, biologic); 5179 age-, sex-, birth region-matched controlsCow's milk allergy before age 2: OR 2.4 (95% CI: 1.6--3.6) in boys; OR 1.1 (95% CI: 0.7, 1.7) in girls; Each 10-liter purchase of hypoallergenic formula in boys: OR 1.02 (95% CI: 1.01, 1.03)Age, sex, region of birth, antibioticsNo direct measurement of dietary dairy consumptionUnexpected sex differencesQuestionable generalizability (1 country, likely exclusion of some oligoarticular JIA)Unmeasured confounding (e.g., genetics, SES, other dietary or environmental factors)Potential reverse causalityKindgren 2019[@CIT0076]1 region, SE SwedenPC (birth cohort 1997--1999 in Southeast Sweden)15,740 children in PC, 42 with JIAOR 4.5 (95% CI: 1.9--10.4) for fish consumption \>1/week during pregnancy, OR 5.1 (95% CI: 2.1--12.4) for fish consumption \>1/week during first year of child's lifeAdjusted for heredity (JIA or RA in first or second degree relative), parity, mode of delivery, prematurity, duration of breastfeeding, introduction of formula, parental age, education, smoking, parents born outside SwedenSmall number of JIA cases identified due to study designNo examination of dose responsePotential selection biasLimited generalizabilityUnmeasured confounding (e.g., SES, genetics, other dietary factors)No recall bias (prospective design)Validated JIA diagnosis by chart review[^1]

### Siblings {#S0002-S2001-S3002}

The hygiene hypothesis[@CIT0031] posits that early exposures to infections (e.g., from older siblings) and non-pathogenic microbiota help protect children against subsequent immune dysfunction and autoimmunity. Children with older siblings tend to have higher level of *Bifidobacteria* commensals early in life, and number of siblings correlates with increased bacterial diversity and richness, which are generally accepted markers of microbial health.[@CIT0016],[@CIT0032],[@CIT0033] Microchimerism---gestational acquisition of cells or DNA from a mother or sibling---represents another mechanism by which JIA risk may be different among children with siblings.[@CIT0034]

Research on the potential effects of siblings in JIA has been variable in size, quality, and findings. One early Danish study with population-based controls and some adjustment for socioeconomic status (SES) suggested that children with JIA were less likely to have household siblings, without relation to sibling age ([Table 1](#T0001){ref-type="table"}).[@CIT0035] Two subsequent population-based case-control studies showed no such relationship: a study of JIA and birth order based on 333 cases in the western US (with minimal confounder adjustment)[@CIT0036] and a study of JIA and number of older siblings based on 3334 hospitalized cases in Sweden.[@CIT0037] Neither study specifically examined the role of siblings in the household, unlike the subsequent Childhood Arthritis Risk Factor Identification Study (CLARITY) from southeast Australia.[@CIT0025],[@CIT0038] This study collected detailed environmental information from 302 cases with JIA and community- and hospital-based controls. The authors reported a decreased risk of JIA among children with household siblings, with some analyses showing additionally diminished risk in those with more siblings (i.e., an apparent dose response). Results were discordant between hospital-based and community-based controls regarding birth order and the dose-response with sibling number for unclear reasons; the sample of community-based controls, while theoretically more valid than hospital-based controls, was also smaller and limited by imprecise estimates in several analyses. Age of JIA diagnosis and closeness in age to siblings did not modify the results. Another recent population-based case-control study used clinic records linked to birth certificates from the northwest US to examine the relationship between JIA and birth order.[@CIT0039] Based on 1234 cases from a single large clinic, this study found an inverse relationship between number of prior births and risk of JIA. Similar trends were observed for multiple JIA categories, although sample size limited the statistical power of subgroup analyses.

In summary, research on the role of breastfeeding and household siblings as potential modifiers of JIA risk has yielded contradictory and inconclusive findings from observational studies of variable quality. More recent studies suggest the possibility that breastfeeding and having multiple siblings may protect from the development of JIA. However, strong conclusions about these effects are limited particularly by concerns about residual confounding from SES and genetic factors. More definitive answers, especially regarding the effects of breastfeeding, may require other designs (e.g., sibling-controlled cohort studies, large randomized trials).

Potentially harmful factors {#S0002-S2002}
---------------------------

### Infectious agents {#S0002-S2002-S3001}

Infection has long been purported to contribute to JIA pathogenesis or trigger JIA flares. Prior reviews have discussed the mixed evidence about bacterial and viral infections as potential triggers of JIA.[@CIT0006],[@CIT0040] Some studies have noted an association between exposure to enteric bacteria (gut pathogens and pathobionts) and enthesitis-related arthritis in developing nations where gastrointestinal infections are more common.[@CIT0041]--[@CIT0043] However, the patho-etiologic role of infections in causing JIA, and the mediating role of genetic factors (e.g., HLA-B27), remain unclear.[@CIT0044]

### Antibiotic exposure {#S0002-S2002-S3002}

Antibiotics can cause profound short-term declines in bacterial diversity and changes in bacterial composition and function.[@CIT0045],[@CIT0046] Typically, microbiota recover within 1--2 months, but some antibiotic-exposed individuals have altered microbial composition for months or years, particularly after repeat antibiotic exposures.[@CIT0047],[@CIT0048] Young children exposed to antibiotics can have altered composition and decreased diversity measured up to two years, changes that correspond to types of antibiotics received.[@CIT0049] Some children with newly diagnosed JIA have higher levels of Bacteroidetes,[@CIT0050],[@CIT0051] a change also seen after antibiotic exposure.[@CIT0049]

Two population-based studies have shown that children diagnosed with JIA are more likely to receive prior antibiotics, and more courses of antibiotics, than age- and sex-matched controls.[@CIT0052],[@CIT0053] One study from Finland showed that children taking antirheumatic drugs for JIA (e.g., oral prednisone, methotrexate, or biologic) were more likely to receive any antibiotics earlier in life, with stronger effects among children with multiple prior courses ([Table 1](#T0001){ref-type="table"}).[@CIT0052] Though uncommonly used, clindamycin exposure was associated with particularly high rates of JIA in a dose-dependent fashion (any use, OR 6.6, 95% CI 3.7--11.7; 2--3 courses, OR 16.0, 95% CI 4.5--56.7). While this study did not adjust for confounding from infections, another nested case-control study from the UK similarly found that cases with JIA were more likely exposed to antibiotics after adjusting for both infections and prior diagnosis of another autoimmune disease ([Table 1](#T0001){ref-type="table"}).[@CIT0053] This association was also dose-dependent as well as time-dependent: the strongest risk of JIA came within one year of antibiotic exposure (OR \~3), with no appreciable association \>2 years after last exposure. These findings were corroborated through secondary definitions of exposure and outcome and robust to multiple sensitivity analyses. One sensitivity analysis showed that antibiotic-treated and presumably viral upper respiratory tract infections were associated with JIA, but untreated URIs were not, further implicating antibiotics as a potential trigger.

Nonetheless, both studies were still observational and could not rule out all sources of bias, notably, residual confounding from unmeasured factors (e.g., genetics) and protopathic bias or reverse causality, whereby underlying immune dysfunction ultimately manifesting in JIA predisposed children to more serious infections before diagnosis.

### Cesarean (C) section delivery {#S0002-S2002-S3003}

The path newborns take leaving the womb may have important immunologic implications. Compared to vaginally delivered infants, those born by cesarean section tend to have lower levels of circulating cytokines and leukocyte responsiveness.[@CIT0054]--[@CIT0056] Children born via elective C-section may also have long-lasting immune deficits compared to children born after labor.[@CIT0057] C-section deliveries also correspond to early decreases in microbial diversity and lower proportions of beneficial Bifidobacteria, particularly elective C-sections without laboring or even abbreviated exposure to the birth canal.[@CIT0017],[@CIT0058],[@CIT0059] Early microbiota disruptions due to mode of delivery might mediate subsequent differences in infants' immune responsiveness.[@CIT0060] Broadly speaking, C-section deliveries could predispose children to subsequent immunologic dysfunction and disorders.[@CIT0061]

Several studies have examined the relationship between mode of delivery and JIA. Two case-control studies, each with 200--300 cases, were unable to show a significant association between mode of delivery and JIA but were underpowered to do so ([Table1](#T0001){ref-type="table"}).[@CIT0025],[@CIT0026] However, three large population-based studies from Scandinavia---a hospital-based case-control study from Sweden and two cohort studies from Denmark---showed small but significantly increased risks of JIA among children born by C-section.[@CIT0037],[@CIT0062],[@CIT0063] The Swedish study and one Danish study both produced effect estimates of similar magnitude: OR 1.15 (95% CI 1.02--1.30) and IRR 1.10 (95% CI 1.02--1.18) ([Table 1](#T0001){ref-type="table"}). The second Danish study suggested that this association changed based on type of C-section: elective C-section was associated with increased risk of JIA (HR 1.25, 95% CI 1.04--1.51) but acute C-section was not (HR 0.99, 95% CI 0.81--1.20). These observations are compatible with the hypothesis that unlabored C-sections may slightly increase the risk of JIA due to changes in post-partum microbiota and immune response. However, such mechanistic explanations are speculative. All of these studies were limited by incomplete adjustment for confounding.

Unclear associations {#S0002-S2003}
--------------------

### Seasonality {#S0002-S2003-S3001}

Clustering of JIA incidence in certain seasons might favor etiologies that peak similarly during certain seasons, such as infections. A study of 28 children with systemic JIA from Kansas, USA, showed peaks in certain months, i.e., spring (May) and autumn (September), that might suggest enteroviral etiology.[@CIT0064] In contrast, a retrospective study within Canadian pediatric rheumatology centers from 1980 to 1992 did not reveal seasonal clustering of new cases with systemic JIA except for increases in JIA incidence in the Prairie region in spring (May) and autumn (September--November); notably, this timing did not coincide with local viral outbreaks.[@CIT0065] Another multicenter retrospective study of 59 patients with systemic JIA in Israel did not demonstrate any obvious season of onset of disease.[@CIT0066] However, another Israeli study of 558 children with multiple types of JIA noted a pattern in patients' months of birth when compared to the general population, with peaks in births from late fall and winter (November--March) and a nadir in summer, particularly for enthesitis-related arthritis.[@CIT0067] The working hypothesis for season of birth as a risk factor in JIA is that an environmental agent (such as infection or sun exposure) during that particular season may trigger an autoimmune process in the fetal or perinatal period.

### Second-hand smoke exposure {#S0002-S2003-S3002}

Personal smoking is the most consistent environmental risk factor linked to the development of seropositive rheumatoid arthritis in adults.[@CIT0068] However, the relationship of JIA incidence to second-hand smoke exposure either *in utero* or in childhood is less clear. Studies from different populations have yielded different results, ranging from null effects to markedly positive associations to modest inverse associations[@CIT0025],[@CIT0026],[@CIT0037],[@CIT0069]--[@CIT0071] ([Table 1](#T0001){ref-type="table"}). Given their many limitations, including unmeasured confounding and potential recall bias, it is difficult to draw strong conclusions from these studies about the role of second-hand smoke exposure on JIA risk.

### Pollutants (air and other occupational exposures) {#S0002-S2003-S3003}

Inhaled air pollutants such as carbon monoxide, sulfur dioxide, ozone, particulate air matter, or nitrates are thought to cause oxidative stress or inflammation leading to systemic autoimmune disease. A case-crossover study from urban regions of Utah, USA, analyzed the association between short-term air conditions and JIA onset, with a focus on fine particulate matter (aerodynamic diameter ≤2.5 µm, or PM~2.5~). Among 338 children diagnosed with JIA, elevated PM~2.5~ concentrations in the preceding 14 days were associated with an increased risk of JIA onset in children younger than 5.5 years (RR 1.6, 95% CI: 1--2.5), with stronger effects seen in boys and children with systemic JIA.[@CIT0072] In a separate study focused on systemic JIA, the same group found an increased relative risk of systemic JIA within 14 days following PM~2.5~ exposure in children under 5.5 years (RR 1.75, 95% CI 0.85--3.62), although this association did not meet traditional levels of statistical significance.[@CIT0073] These studies were limited by their consideration only of short-term pollutant exposures and lack of adjustment for other time-varying confounders (e.g., infections).

A Brazilian study conducted over 7 years (2000--2007) studied the relationships between daily concentrations of inhaled particulate matter (PM~10~), sulfur dioxide (SO~2~), nitrogen dioxide (NO~2~), ozone (O~3~), and carbon monoxide (CO) and hospital admissions for several pediatric rheumatic diseases, including JIA, systemic lupus, dermatomyositis, systemic scleroderma, ankylosing spondylitis, and vasculitis. This study reported an association between SO~2~ and pediatric rheumatic disease admissions following a 2-week lag.[@CIT0074] They did not report JIA admissions and pollutant exposure and it would seem that JIA patients are less often admitted to the hospital thus limiting this study. Another Brazilian case-control study of 66 JIA and 124 age- and sex-matched healthy controls residing in Sao Paulo found increased risk of maternal occupational exposure during pregnancy to inhalable particulate pollutants and/or volatile vapor with OR 13.7 (95% CI: 4.4--42.3) using a structured questionnaire.[@CIT0071] This study was limited by potential bias from unmeasured confounding and potential referral bias from use of convenience sample from a tertiary center and recall bias.

### Perinatal risk factors {#S0002-S2003-S3004}

The study by Carlens et al reported borderline associations between JIA and the following perinatal characteristics: post-dates delivery (\>42 weeks gestation), OR 1.3 (95% CI: 1--1.3); and Apgar scores ≤6 at 5 mins, OR 0.7 (95% CI: 0.5--1). No significant associations were found between JIA and other perinatal risk factors, including maternal age, birthweight, multiple births, malformations, birth season, or maternal-child blood group incompatibility.[@CIT0037] Similarly, Shenoi et al did not find any association between JIA diagnosis and birth weight or place of delivery. However, children born pre-term were more likely to develop JIA (OR 1.8, 95% CI: 1.2--2.7).[@CIT0026] The limitations of these studies have been discussed previously (see [Table 1](#T0001){ref-type="table"}).

### Dietary factors {#S0002-S2003-S3005}

Families of children with JIA often perceive that diet plays an important role in modulation of disease activity.[@CIT0075] This raises the question of whether dietary factors could contribute to pathogenesis. A Swedish-population-based cohort study found that fish consumption (\>1 time per week) during pregnancy or in the first year of a child's life was associated with a markedly increased risk of developing JIA. Additionally, the authors reported higher levels of aluminum, mercury, cadmium, and lithium in the cord blood of children with JIA compared to controls, supporting the hypothesis that the association is mediated by exposure to heavy metals in fish ([Table 1](#T0001){ref-type="table"}).[@CIT0076] This study did not, however, report the presence of a clear dose-response or the influence of confounding from other dietary or environmental factors. A population-based study from Finland showed that boys diagnosed with a cow's milk allergy and exposed to hypoallergenic formula before age 2 were more likely to develop JIA ([Table 1](#T0001){ref-type="table"}).[@CIT0077] This association was not present in girls, raising questions about the biologic mechanism and relevance of this unexpected sex difference. Of note, this study did not directly examine the effect of early-life consumption of dairy products and had similar limitations to the prior Finnish study on antibiotics and JIA, including unmeasured confounding ([Table 1](#T0001){ref-type="table"}).[@CIT0052]

### Sun exposure and vitamin D {#S0002-S2003-S3006}

Multiple studies have shown that vitamin D levels are generally low in children diagnosed with JIA and may correspond to disease activity and manifestations,[@CIT0078],[@CIT0079] but few studies have explored whether vitamin D plays a role in JIA incidence, none via examination of dietary vitamin D intake. A Danish case-cohort study of 300 matched pairs of oligo and polyarticular JIA did not find any association between vitamin D levels at birth (assessed by neonatal dried blood spots) and subsequent JIA development (OR 1.2; 95% CI: 0.9--1.6).[@CIT0080] Using CLARITY data, a sub-study of 202 Caucasian JIA age-matched case-control pairs born in Victoria Australia and matched on birth year and time of recruitment demonstrated that higher cumulative ultraviolet radiation or sun exposure was associated with significantly reduced risk for subsequent JIA development.[@CIT0081] They also found that higher the sun exposure during 12 weeks of pregnancy lower the risk for JIA and hypothesized that the mechanism through which sun exposure might influence JIA risk is through active vitamin D circulating levels. Using SNP data from the CLARITY study, Ellis et al also demonstrated that epistasis (gene--gene interaction) between PTPN2 and vitamin D pathway genes might contribute to risk of JIA.[@CIT0082]

### Miscellaneous risk factors {#S0002-S2003-S3007}

Other factors have been studied in JIA including SES (higher income parents higher risk (RR 1.9) of JIA)[@CIT0035]Residence (urban residence had increased risk RR 2.7,[@CIT0035] or no risk with area of residence)[@CIT0026]Animal exposure (pet exposure during infancy was not related to oligoarticular JIA (OR 0.79),[@CIT0028] or household pet exposure was not associated with JIA)[@CIT0026] andStressors[@CIT0083](no risk,[@CIT0026] or strong association with stressors antedating first clinic visit)[@CIT0084]

These studies are relatively small and show inconsistent results making it difficult to determine causal nature of associations.

Common limitations of environmental research {#S0003}
============================================

The vast majority of studies investigating environmental links to diseases such as JIA are observational, leading to inevitable questions about whether epidemiologic associations imply causality. Investigators may not measure or account for factors relating independently to an environmental exposure and the outcome (for instance, SES, genetic, and other environmental factors), potentially distorting the true associations through confounding. Long latency times between exposures (e.g., prenatal and perinatal factors) and outcomes make confounding more likely. Furthermore, when participants self-report remote environmental exposures, the findings may be impacted by faulty recall (exposure misclassification) and differential recall between cases and controls (recall bias). Selection of proper controls in case-control studies (the most commonly used design cited in this review) is critical to making valid comparisons between groups. Selecting controls by convenience (e.g., hospital-based controls) or in ways that do not represent the same population source as cases can lead to selection bias. Other challenges to interpreting observational studies on environmental exposures may relate to uncertainties about when environmental risks have the most impact on disease development; synergistic effects among multiple exposures or with genetic factors (gene--environment interactions); and use of highly curated cases that limit generalizability to broader populations (e.g., single-center studies). Additional challenges arise in research on JIA, including heterogeneity of disease, evolving and inconsistent disease classification, low disease incidence leading to small sample sizes, and lack of standardized registries.

Conclusion {#S0004}
==========

Evidence on the role of environmental factors in the development of JIA is slowly expanding, including potential protective influences from breast feeding and household siblings and potential risks from antibiotic exposure and C-section deliveries. Nonetheless, many uncertainties remain about the role of these and other factors in JIA pathogenesis. The role of diet in JIA, while of greater interest to patients and caregivers, remains largely unexplored. More definitive findings about the role of purported and novel yet unidentified environmental factors in JIA pathogenesis will require robust study designs applied to large populations along with mechanistic studies. Such approaches should leverage the tools of systems biology and examine how environmental factors (the "exposome") interact with genomics, epigenomics, and the microbiome other -omics in children who develop or are at risk for JIA. The confirmation of true environmental protective and risk factors for JIA  will help inform policies and interventions that could one day help prevent JIA in susceptible children and improve patient outcomes.
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[^1]: **Notes:** ^1^Calculated based on numbers presented in paper; inverse effect measures were calculated to ensure consistent comparator groups across analyses; summary measures from multiple-group results were produced by fixed effects meta-analysis. ^2^Physician global, parent global, and pain scores out of total 100 (worst possible); CHAQ scores out of total 3 (worst possible).

    **Abbreviations:** ACR, American College of Rheumatology; aHR, adjusted hazard ratio; aIRR, adjusted incidence rate ratio; aOR, adjusted odds ratio; ARA, American Rheumatism Association; BF, breastfeeding; CC, case-control study; CHAQ, Child Health Assessment Questionnaire (JIA functional assessment); CS, cesarean section; EULAR, European League of Associations for Rheumatology; HC, healthy control; HR, hazard ratio; ICD-10, International Classification of Diseases, 10th Revision; ILAR, International League Against Rheumatism; IRR, incident rate ratio; JCA, juvenile chronic arthritis; JIA, juvenile idiopathic arthritis; JRA, juvenile rheumatoid arthritis; NCC, nested case-control study; NR, not reported; NW, northwest; OR, odds ratio; PC, prospective cohort study; PGA, parent global score; PhGA, physician global score; RC, retrospective cohort study; SD, standard deviation; SE, southeast; SES, socioeconomic status; SW, southwest; TA, transient arthritis; US, United States.
